Related Experiment Video
Updated: Oct 9, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report
Waail Rozi1, Elrazi Awadelkarim Hamid Ali1, Abdulrahman F Al-Mashdali1
1Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Introduction:
Sickle cell disease (SCD) is a hematological disorder characterized by sickling of red blood cells. Patients are at increased risk of venous thromboembolism. There are no guidelines for the management of venous thromboembolism in sickle cell disease specifically in terms of the anticoagulant of choice.
Patient Concerns:
Here, we report a case of a 30-year-old lady with past medical history of sickle cell disease who came with chest pain and shortness of breath.
Diagnosis:
We found that she has bilateral pulmonary embolism (PE).
Intervention:
She was started on rivaroxaban.
Outcome:
The patient was followed for 18 months, she did not suffer from recurrence of PE, and she did not develop any complications related to rivaroxaban.
Conclusion:
We concluded that rivaroxaban is effective in treating PE in sicklers and also it is safe.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

